NAD+ Injection Pen: Buyer's Guide for UK Aesthetic Practitioners
Quick answer: A NAD+ injection pen is a delivery device used to administer nicotinamide adenine dinucleotide (NAD+) via injection, distinct from the formulation itself. Before purchasing, practitioners should check whether a product is device-only, a refill, or a complete kit, confirm the NAD+ concentration and dosing protocol, and review batch documentation, sterility evidence, and regulatory status before adding it to their clinic.
NAD+ has moved from longevity research circles into mainstream aesthetic and wellness clinics, and the NAD+ injection pen format is increasingly marketed as a convenient way to administer it. But "convenient" and "clinically justified" are two separate questions, and clinic buyers researching this category are often presented with pens, vials, and kits that look similar on the surface but differ substantially in what's actually inside the box.
This guide walks through what a NAD+ injection pen is, how the device relates to the formulation it delivers, what the current evidence base actually shows, and what to check before you commit clinic budget to a purchase. It's written for UK aesthetic practitioners and clinic buyers evaluating this category, not for consumers self-administering at home.
What is a NAD+ injection pen?
What does NAD+ actually mean?
NAD+ (nicotinamide adenine dinucleotide) is a coenzyme that sits at the centre of cellular energy metabolism. According to Covarrubias et al. (2021), published in Nature Reviews Molecular Cell Biology, NAD+ is an essential cofactor for enzymes including sirtuins, PARPs, and CD38, and NAD+ levels are known to decline with age. This biological role is well established and is the reason NAD+ has attracted attention in longevity and cellular health research.
What's important for clinic buyers to separate out is that NAD+ the molecule, and the device used to inject it, are two distinct things. A NAD+ injection pen is a delivery mechanism. The clinical relevance of any given product depends on what's inside the cartridge, not on the pen housing itself.
The pen and its contents are separate components
When researching this category, you'll typically encounter three purchasing structures:
- Pen-only: A reusable injector device sold without any NAD+ formulation. You supply your own compatible cartridge or vial separately.
- Refill cartridges: Pre-filled cartridges of NAD+ formulation designed to be used with a specific pen device.
- Complete kits: The pen device and formulation sold together as a single product.
It's also worth confirming whether a product actually contains NAD+ itself, or a precursor such as NR (nicotinamide riboside) or NMN (nicotinamide mononucleotide). These precursors are metabolised into NAD+ in the body, but they are chemically distinct from NAD+ and are not interchangeable for dosing or evidence purposes. A product listing "NAD+ boosting" ingredients isn't necessarily delivering NAD+ directly.
How does a NAD+ injection pen work?
Device design and compatibility
NAD+ injection pens vary by design. Some are reusable devices intended to be paired with replacement cartridges over time; others are disposable, single-use pens discarded after the cartridge is depleted. Needle compatibility also differs between manufacturers, and cartridges from one brand are not guaranteed to fit another brand's device.
Why instructions are product-specific
This is where generic guidance becomes risky. Total pack content, NAD+ concentration per cartridge, and the prescribed dosing schedule all vary by manufacturer. Device markings — the increments shown on the dial or barrel — are calibrated to that specific product's concentration. Applying instructions from one NAD+ injection pen to a different manufacturer's device can result in significant dosing errors. Always follow the instructions for use supplied with the specific product you're stocking, not general guidance found elsewhere.
NAD+ pen vs vial, IV infusion and oral products
Clinics researching NAD+ delivery typically compare four formats. Each carries different practical requirements and a different evidence position.
|
Format |
Actual ingredient delivered |
Administration setting |
Practical requirements |
Cost components |
|---|---|---|---|---|
|
NAD+ injection pen |
NAD+ (formulation-dependent; confirm concentration) |
Subcutaneous injection, clinic or self-administered per product licensing |
Device + cartridge compatibility, sharps disposal, training |
Device cost (if applicable) + cartridge/refill cost |
|
NAD+ vial (vial + syringe) |
NAD+ (formulation-dependent) |
Subcutaneous or intramuscular injection, clinic setting |
Syringe, needle, reconstitution if lyophilised |
Per-vial cost + consumables |
|
IV infusion |
NAD+ delivered intravenously |
Clinical setting, typically longer session |
IV line, trained staff, monitoring time |
Higher per-session cost due to time and consumables |
|
Oral NAD+ precursor (NR/NMN) |
Precursor molecule, not NAD+ directly |
Self-administered, no clinic visit required |
None beyond the product itself |
Lower unit cost but ongoing daily purchase |
Cost, convenience, and evidence don't move together across these formats. A pen may offer more convenient administration than an IV infusion, but convenience is a separate question from how much clinical benefit that administration route delivers — a distinction worth holding onto when evaluating supplier claims.
What evidence supports NAD+ injection pen benefits?
Biological plausibility versus demonstrated benefit
The biological case for NAD+'s role in cellular energy metabolism is well documented in the research literature, including the Covarrubias et al. (2021) review referenced above. This establishes why NAD+ matters at a cellular level. It does not, on its own, establish that injecting NAD+ via a pen device produces a specific, measurable clinical outcome in a healthy adult population.
What human studies have actually measured
Where human studies exist, they have generally focused on measuring NAD+ levels in blood or tissue following supplementation, alongside markers related to metabolism and cellular ageing pathways. Practitioners should look closely at what a given study measured — a change in NAD+ levels is not the same as a demonstrated improvement in energy, recovery, or a specific clinical endpoint.
What remains uncertain
Optimal dosing, injection frequency, and the comparative effectiveness of injectable NAD+ against oral precursors in humans remain active areas of research rather than settled questions. Choose your positioning with patients and colleagues accordingly: describe what NAD+ does at a cellular level, and be precise about the boundary between that mechanism and any outcome claim.
What should you check before buying a NAD+ injection pen?
Before committing clinic budget, work through this checklist:
Identity, formulation and intended use
- Confirm the product delivers NAD+ directly, rather than a precursor such as NR or NMN.
- Confirm whether you're buying a device only, a refill, or a complete kit.
- Confirm the product is licensed and labelled for professional use, not consumer self-administration, if that's your intended context.
Quality documentation
- Batch number and expiry date on the specific unit you receive.
- Instructions for use specific to that product's concentration and dosing protocol.
- Sterility and endotoxin documentation appropriate to an injectable product.
- A Certificate of Analysis confirming the cartridge contents match the labelled concentration.
Kit completeness and support
- Confirm exactly what's included in the box — device, cartridges, needles, or formulation only.
- Confirm what happens when the cartridge runs out: is a compatible refill readily available from the same supplier?
- Confirm what documentation and support the supplier provides if you need to answer a practitioner's or patient's question later.
NAD+ injection pen safety and clinical oversight
Any injectable product, including a NAD+ injection pen, carries the standard risks associated with injection technique, including infection risk if sterility is compromised and incorrect dosing if instructions are misapplied. Products marketed for professional use only should be administered exclusively by trained, insured practitioners, following the specific instructions for use supplied with that product. Do not extrapolate dosing or administration guidance from one manufacturer's device to another.
How much does a NAD+ injection pen cost?
Comparing equivalent purchases
Pricing structures vary depending on what you're actually buying:
- Device-only pricing covers the reusable injector, with cartridges purchased separately on an ongoing basis.
- Starter kit pricing bundles the device and an initial cartridge supply together.
- Refill pricing applies once you already own a compatible device and are purchasing replacement cartridges.
What determines ongoing cost
Ongoing cost per clinic is driven by cartridge concentration, the number of doses per cartridge, and how frequently your protocol calls for administration. A higher upfront cartridge price may still work out more cost-effective per dose if it delivers more doses per unit — so compare cost per dose, not just cost per unit, when evaluating suppliers.
Storage, shelf life and delivery
Storage and shelf-life requirements for NAD+ formulations vary by manufacturer and by whether the product is supplied lyophilised (requiring reconstitution) or pre-mixed. Refrigeration requirements, once opened, and total shelf life should always be confirmed against the specific product's instructions for use — guidance for one brand's cartridge should not be assumed to apply to a different manufacturer's product, given differences in formulation and stabilisers.
Reviewing IGO's NADura+ NAD injection pen
IGO Aesthetics' NADura+ NAD Injection Pen (1 x 1000mg) delivers 1000mg of NAD+ per pen, with 20 precise doses per cartridge. It's built around a structured protocol: a loading phase across days 1–3, followed by a maintenance phase from day 4 onwards. The product is listed for professional use only, and purchasers are required to confirm they are a qualified, insured practitioner before buying.
At the time of writing, the NADura+ pen is priced at $207.00 and is currently out of stock. Clinics interested in stocking this product can view current availability or request documentation directly via the product listing.
As with any NAD+ injection pen, the value of the device format is separate from the strength of the clinical evidence behind NAD+ supplementation generally — a distinction worth communicating clearly to colleagues and patients alike.
Where to go from here
Choosing a NAD+ injection pen for your clinic comes down to three separate questions: does the product deliver NAD+ directly and at a confirmed concentration, does the supplier provide the documentation your insurance and regulatory position require, and does the ongoing cost per dose make sense for your treatment menu. Keep these questions distinct from claims about outcomes, and request full documentation before adding any new injectable to your clinic.
If you're evaluating options, review the NADura+ NAD Injection Pen listing or contact IGO Aesthetics directly for product documentation and stock updates.
Frequently Asked Questions
Is a NAD+ injection pen the same as a NAD+ skin booster?
No. A NAD+ injection pen is a systemic delivery device for NAD+, typically used for cellular energy and longevity-focused protocols. A skin booster is formulated and administered specifically to improve skin quality, usually via a different injection technique and product category entirely.
Does a NAD+ injection pen kit include the formulation, or just the device?
This depends entirely on the specific product. Some kits include both the pen and the NAD+ formulation; others sell the device separately from refill cartridges. Always check the product listing to confirm exactly what's included before purchasing.
Is a NAD+ injection pen reusable?
Some pen devices are designed to be reusable with replacement cartridges, while others are single-use and disposed of once the cartridge is depleted. This varies by manufacturer, so check the specific product's design before assuming reusability.
How long does 1000mg of NAD+ last in a pen like NADura+?
The NADura+ pen provides 20 precise doses per 1000mg cartridge. How long that supply lasts in practice depends on the prescribed protocol — including the loading phase (days 1–3) and maintenance phase (day 4 onwards) — rather than a fixed universal timeframe.
Does a NAD+ injection pen need refrigeration?
Storage requirements vary by manufacturer and formulation. Always follow the instructions for use supplied with the specific product you're stocking rather than applying guidance from a different brand's cartridge.
What evidence supports the benefits of NAD+ injection pens?
NAD+'s biological role in cellular energy metabolism is well established in the research literature, including Covarrubias et al. (2021). However, this establishes biological plausibility rather than a demonstrated clinical outcome specific to pen-based injection. Human studies to date have generally measured changes in NAD+ levels rather than specific outcome endpoints.
What are the UK prescription and supply requirements for NAD+ injection pens?
Products marketed for professional use only require purchasers to confirm they are trained, licensed, and insured practitioners. Always check the specific regulatory and supply status of the product you're sourcing, and administer only within your scope of practice.
Are NAD+ pen cartridges compatible across different brands?
No, not generally. Cartridge and needle compatibility is manufacturer-specific, and cartridges from one brand should not be assumed to fit another brand's pen device. Confirm compatibility directly with the supplier before purchasing refills.